Oncology late-stage portfolio update

Key Data at ASCO 2022
- Glofitamab pivotal Ph1b data in 3L+DLBCL
- Polivy Asian sub-population data from Ph3 POLARIX in 1L DLBCL

Oncology early R&D update

Q&A

Elena Bernedo-Arzac, SVP, Oncology Therapeutic Area Head

Ginna Laporte, MD VP, Global Head Lymphoma/CLL Clinical Development

Johanna Bendell, M.D., Head of Roche Pharma Research and Early Development (pRED) Oncology
Andy Chan, M.D., Ph.D. Senior Vice President, Research Biology, Genentech Research & Early Development (gRED)